FDA approves weight-loss drug Zepbound for obstructive sleep apnea - WSVN

The FDA approved Zepbound, a weight-loss drug, for treating moderate to severe obstructive sleep apnea in obese individuals. It should be used with a reduced-calorie diet and increased physical activity. Clinical trials showed significant improvements in sleep apnea symptoms and weight loss.